Fasting recommended (see description for details). A test that measures levels of insulin in the blood, a hormone secreted by the pancreas which is involved in glucose regulation.
[hbA1C, A1C] – A measure of average blood glucose (or blood sugar) levels averaged over the last 2 to 3 months. Medical professionals often use this test in combination with others to diagnose risk of diabetes.
[CMP] Fasting recommended (see description for details). Similar to the Basic Metabolic Panel (8), this is a blood test that checks several substances in the blood, including glucose (blood sugar), electrolytes, and markers of kidney function. However, the Comprehensive panel also looks at markers of liver function. It is also one of the most commonly ordered tests.
Please note some items tested on the Comprehensive Metabolic Panel are also tested via: the Basic Metabolic Panel (8), Electrolyte Panel, Renal Panel (10) and Hepatic Function Panel (7) (see description on individual product pages for more information to avoid redundant test ordering).
The Lipid Panel measures both cholesterol (total, LDL, and HDL) and fat (triglycerides) in the blood. These four metrics are commonly used as risk factors for cardiovascular disease.
Please note this test measures the same items as: the lipid panel with Total Cholesterol:HDL ratio, or lipid panel with LDL:HDL ratio, with the only difference being no ratio calculation is reported with the results (instead of Total Cholesterol:HDL Ratio, or LDL:HDL ratio respectively).
[CRP, hsCRP] Also known as hs-CRP or High Sensitivity C-Reactive Protein. C-Reactive Protein is a protein made by the liver. Levels of CRP are typically associated with inflammation in the body. It is often used to detect risk in both acute and chronic conditions involving an inflammatory response.
A test that integrates the protein levels and glycosylation states of several of the most abundant acute-phase proteins in serum allowing for a more stable measure of systemic inflammation. Sometimes used to aid in the identification and stratification of individuals at risk for future cardiovascular disease.